Serial O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma

@article{Poepperl2005SerialOP,
  title={Serial O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma},
  author={Gabriele Poepperl and Claudia G{\"o}tz and Walter Rachinger and Oliver Schnell and Franz Josef Gildehaus and Joerg Christian Tonn and Klaus Tatsch},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2005},
  volume={33},
  pages={792 - 800}
}
Intracavitary radioimmunotherapy (RIT) offers an effective adjuvant therapeutic approach in patients with malignant gliomas. Since differentiation between recurrence and reactive changes following RIT has a critical impact on patient management, the aim of this study was to analyse the value of serial O-(2-[18F]fluoroethyl)-l-tyrosine (FET) PET scans in monitoring the effects of this locoregional treatment. Following conventional therapy, 24 glioma patients (5 WHO III, 19 WHO IV) underwent one… CONTINUE READING